» Articles » PMID: 34602076

Negative Correlation Between Endoglin Levels and Coronary Atherosclerosis

Overview
Publisher Biomed Central
Date 2021 Oct 4
PMID 34602076
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronary artery disease (CAD) is a common cardiovascular disease, and abnormal blood lipid metabolism is an important risk factor. Transforming growth factor-ß (TGF-ß) and its receptor (TGF-ßR) can inhibit the release of inflammatory factors through the SMAD pathway-mediated immune response, thereby suppressing the progression of CAD. Endoglin (TGF-ßRIII), a TGF-ßR family homologous receptor protein, is directly involved in the immunoregulatory process, but the exact mechanism is unclear. This study aimed to clarify the pathophysiological effects of endoglin on the development of atherosclerosis and to explore the mechanism of the signalling pathway.

Methods: We downloaded the GEO dataset to perform a functional analysis of SMAD family activity and TGF-ß receptor protein expression in the monocyte expression profiles of patients with familial hyperlipidaemia (FH). The effect of endoglin on endothelial cell proliferation, migration, and apoptosis was examined by disrupting the endoglin gene in human umbilical vein endothelial cells (HUVECs) and validated by western blotting. The related genes and pathways regulated by endoglin were obtained by analysing the sequencing data.

Results: Research has shown that interference with endoglin can promote the proliferation and migration and significantly inhibit the apoptosis of vascular endothelial cells. Interference with endoglin particularly encourages the expression of VEGFB in vascular endothelial cells.

Conclusion: The endoglin gene in vascular endothelial cells regulates the PI3K-Akt, Wnt, TNF, and cellular metabolism pathways by activating the SMAD pathway. RAB26, MR1, CCL2, SLC29A4, IBTK, VEGFB, and GOLGA8B play critical roles. Endoglin interacts closely with 11 proteins such as CCL2 and SEPRINE1, which participate in the vital pathway of plaque formation. Interference with endoglin can alter the course of coronary atherosclerosis.

Citing Articles

Elucidating the role of KCTD10 in coronary atherosclerosis: Harnessing bioinformatics and machine learning to advance understanding.

Hu X, Liang F, Zheng M, Xie J, Wang S Sci Rep. 2025; 15(1):8168.

PMID: 40059128 PMC: 11891306. DOI: 10.1038/s41598-025-91376-3.


Integrative bioinformatics and machine learning approach unveils potential biomarkers linking coronary atherosclerosis and fatty acid metabolism-associated gene.

Li H, Xu Y, Wang A, Zhao C, Zheng M, Xiang C J Cardiothorac Surg. 2025; 20(1):70.

PMID: 39825440 PMC: 11742484. DOI: 10.1186/s13019-024-03199-4.


Activins and Inhibins in Cardiovascular Pathophysiology.

Tang W, Gu Z, Guo J, Lin M, Tao H, Jia D Biomolecules. 2024; 14(11).

PMID: 39595638 PMC: 11592067. DOI: 10.3390/biom14111462.


Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel.

Li H, Wang X, Zhai M, Xu C, Chen X Discov Oncol. 2024; 15(1):152.

PMID: 38730195 PMC: 11087400. DOI: 10.1007/s12672-024-00973-7.


Unlocking potential biomarkers bridging coronary atherosclerosis and pyrimidine metabolism-associated genes through an integrated bioinformatics and machine learning approach.

Bu F, Qin X, Wang T, Li N, Zheng M, Wu Z BMC Cardiovasc Disord. 2024; 24(1):148.

PMID: 38454353 PMC: 10921789. DOI: 10.1186/s12872-024-03819-w.


References
1.
Li X, van der Meer J, van der Loos C, Ploegmakers H, de Boer O, de Winter R . Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease. Histopathology. 2012; 61(1):88-97. DOI: 10.1111/j.1365-2559.2011.04166.x. View

2.
Conley B, Smith J, Bernabeu C, Vary C . Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis. 2001; 153(2):323-35. DOI: 10.1016/s0021-9150(00)00422-6. View

3.
Hansson G, Libby P . The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006; 6(7):508-19. DOI: 10.1038/nri1882. View

4.
Li Y, Shyy Y, Wright J, Valente A, Cornhill J, Kolattukudy P . The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol Cell Biochem. 1993; 126(1):61-8. DOI: 10.1007/BF01772208. View

5.
Grainger D . TGF-beta and atherosclerosis in man. Cardiovasc Res. 2007; 74(2):213-22. DOI: 10.1016/j.cardiores.2007.02.022. View